Highly frequent allelic loss of chromosome 6q16-23 in osteosarcoma: Involvement of cyclin C in osteosarcoma

International Journal of Molecular Medicine

Volumn 18, Issue 6, 2006, Pages 1153-1158

  Ohata, Norihide ^a   Ito, Sachio ^a   Yoshida, Aki ^a   Kunisada, Toshiyuki ^a   Numoto, Kunihiko ^a   Jitsumori, Yoshimi ^a   Kanzaki, Hirotaka ^a   Ozaki, Toshifumi ^a   Shimizu, Kenji ^a   Ouchida, Mamoru ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Chromosomal aberration; Comparative genomic hybridization; cyclin C; Loss of heterozygosity; Osteosarcoma

Indexed keywords

CCNC PROTEIN, HUMAN; COMPLEMENTARY DNA; CYCLINE; MESSENGER RNA; MICROSATELLITE DNA;

ARTICLE; CHROMOSOME 6; CHROMOSOME MAP; COMPARATIVE STUDY; GENE DELETION; GENETIC MARKER; GENETICS; HETEROZYGOSITY LOSS; HUMAN; METABOLISM; NUCLEIC ACID HYBRIDIZATION; OSTEOSARCOMA; PATHOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 6; CYCLINS; DNA, COMPLEMENTARY; GENE DELETION; GENETIC MARKERS; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; NUCLEIC ACID HYBRIDIZATION; OSTEOSARCOMA; PHYSICAL CHROMOSOME MAPPING; RNA, MESSENGER;

EID: 39049188432     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.18.6.1153     Document Type: Article

References (21)

1. Sandberg AA and Bridge JA: Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors. Cancer Genet Cytogenet 145: 1-30, 2003.
2. Bridge JA, Nelson M, McComb E, McGuire MH, Rosenthal H, Vergara G, Maale GE, Spanier S and Neff JR: Cytogenetic findings in 73 osteosarcoma specimens and a review of the literature. Cancer Genet Cytogenet 95: 74-87, 1997. (Pubitemid 27188450)
3. Benassi MS, Molendini L, Gamberi G, Magagnoli G, Ragazzini P, Gobbi GA, Sangiorgi L, Pazzaglia L, Asp J, Brantsing C and Picci P: Involvement of INK4A gene products in the pathogenesis and development of human osteosarcoma. Cancer 92: 3062-3067, 2001.
4. Tsuchiya T, Sekine K, Hinohara S, Namiki T, Nobori T and Kaneko Y: Analysis of the p16INK4, p14ARF, p15, TP53, and MDM2 genes and their prognostic implications in osteosarcoma and Ewing sarcoma. Cancer Genet Cytogenet 120: 91-98, 2000.
5. Nielsen GP, Burns KL, Rosenberg AE and Louis DN: CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations. Am J Pathol 153: 159-163, 1998.
6. Wei G, Lonardo F, Ueda T, Kim T, Huvos AG, Healey JH and Ladanyi M: CDK4 gene amplification in osteosarcoma: reciprocal relationship with INK4A gene alterations and mapping of 12q13 amplicons. Int J Cancer 80: 199-204, 1999.
7. Yamaguchi T, Toguchida J, Yamamuro T, Kotoura Y, Takada N, Kawaguchi N, Kaneko Y, Nakamura Y, Sasaki MS and Ishizaki K: Allelotype analysis in osteosarcomas: frequent allele loss on 3q, 13q, 17p, and 18q. Cancer Res 52: 2419-2423, 1992.
8. Horstmann MA, Posl M, Scholz RB, Anderegg B, Simon P, Baumgaertl K, Delling G and Kabisch H: Frequent reduction or loss of DCC gene expression in human osteosarcoma. Br J Cancer 75: 1309-1317, 1997.
9. Ozaki T, Schaefer KL, Wai D, Buerger H, Flege S, Lindner N, Kevric M, Diallo R, Bankfalvi A, Brinkschmidt C, Juergens H, Winkelmann W, Dockhorn-Dworniczak B, Bielack SS and Poremba C: Genetic imbalances revealed by comparative genomic hybridization in osteosarcomas. Int J Cancer 102: 355-365, 2002.
10. Tarkkanen M, Elomaa I, Blomqvist C, Kellokumpu-Lehtinen P, Kivioja AH, Bohling T, Valle J and Knuutila S: DNA sequence copy number increase at 8q: a potential new prognostic marker in high-grade osteosarcoma. Int J Cancer 84: 114-121, 1999.
11. Stock C, Kager L, Fink FM, Gadner H and Ambros PF: Chromosomal regions involved in the pathogenesis of osteosarcomas. Genes Chromosomes Cancer 28: 329-336, 2000.
12. Li BC, Chan WY, Li CY, Chow C, Ng EK and Chung SC: Allelic loss of chromosome 6q in gastric carcinoma. Diagn Mol Pathol 12: 193-200, 2003.
13. Konishi N, Nakamura M, Kishi M, Ishida E, Shimada K, Matsuyoshi S, Nagai H and Emi M: Genetic mapping of allelic loss on chromosome 6q within heterogeneous prostate carcinoma. Cancer Sci 94: 764-768, 2003.
14. Hyytinen ER, Saadut R, Chen C, Paull L, Koivisto PA, Vessella RL, Frierson HF Jr and Dong JT: Defining the region(s) of deletion at 6q16-q22 in human prostate cancer. Genes Chromosomes Cancer 34: 306-312, 2002.
15. Takeuchi S, Koike M, Seriu T, Bartram CR, Schrappe M, Reiter A, Park S, Taub HE, Kubonishi I, Miyoshi I and Koeffler HP: Frequent loss of heterozygosity on the long arm of chromosome 6: identification of two distinct regions of deletion in childhood acute lymphoblastic leukemia. Cancer Res 58: 2618-2623, 1998.
16. Akoulitchev S, Chuikov S and Reinberg D: TFIIH is negatively regulated by cdk8-containing mediator complexes. Nature 407: 102-106, 2000.
17. Polly P, Danielsson C, Schrader M and Carlberg C: Cyclin C is a primary 1alpha,25-dihydroxyvitamin D(3) responding gene. J Cell Biochem 77: 75-81, 2000.
18. Li H, Lahti JM, Valentine M, Saito M, Reed SI, Look AT and Kidd VJ: Molecular cloning and chromosomal localization of the human cyclin C (CCNC) and cyclin E (CCNE) genes: deletion of the CCNC gene in human tumors. Genomics 32: 253-259, 1996.
19. Pietenpol JA, Bohlander SK, Sato Y, Papadopoulos N, Liu B, Friedman C, Trask BJ, Roberts JM, Kinzler KW and Rowley JD: Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias. Cancer Res 55: 1206-1210, 1995.
20. Gao CY and Zelenka PS: Cyclins, cyclin-dependent kinases and differentiation. Bioessays 19: 307-315, 1997.
21. Ren S and Rollins BJ: Cyclin C/cdk3 promotes Rb-dependent G0 exit. Cell 117: 239-251, 2004.